Update on Once-Monthly Weight Loss Drug Maritide Following Phase II Clinical Trial The Phase II trial of the once-monthly weight loss drug Maridebart cafraglutide (Amgen), also known as MariTide or AMG133, shows high discontinuation rates, largely due to gastrointestinal side effects
Came with everything needed, syringes, alcohol pads, arrived on ice
Can peptides help with the loose skin from rapid weight loss
I'm Gabriel Abrams, founder of Elite Mobile IV, where I've administered thousands of myers cocktail iv drip treatments to clients seeking convenient, at-home wellness support
He shares PET imaging data, results from a 6-month MCT trial in mild cognitive impairment, and why ketogenic and ketone-based therapies could help preserve cognition in neurodegenerative diseases, especially when combined with exercise and modest carbohydrate restriction